Trial Profile
A Long-term Follow-up Study of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Jul 2023
Price :
$35
*
At a glance
- Drugs GSK 3277511 (Primary)
- Indications Respiratory tract disorders
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 24 Apr 2020 Status changed from active, no longer recruiting to completed.
- 25 Nov 2019 Planned End Date changed from 25 Mar 2020 to 26 Mar 2020.
- 28 Sep 2017 Status changed from recruiting to active, no longer recruiting.